Medicinal chemistry updates of novel HDACs inhibitors (2020 to present)

Volume: 227, Pages: 113946 - 113946
Published: Jan 1, 2022
Abstract
Epigentic enzymes histone deacetylases (HDACs) catalyze the removal of acetyl groups from the ε-N-acetylated lysine residues of various protein substrates including both histone and non-histone proteins. Different HDACs have distinct biological functions and are recruited to specific regions of the genome. Due to their important biological functions, HDACs have been validated in clinics for anticancer therapy, and are being explored for...
Paper Details
Title
Medicinal chemistry updates of novel HDACs inhibitors (2020 to present)
Published Date
Jan 1, 2022
Volume
227
Pages
113946 - 113946
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.